155 related articles for article (PubMed ID: 1618694)
41. Lung cancer screening--comparison of computed tomography and X-ray.
Fujikawa A; Takiguchi Y; Mizuno S; Uruma T; Suzuki K; Nagao K; Niijima M; Edo H; Hino M; Kuriyama T
Lung Cancer; 2008 Aug; 61(2):195-201. PubMed ID: 18242764
[TBL] [Abstract][Full Text] [Related]
42. The efficacy of sputum cytology in mass screening program for early detection of lung cancer.
Sagawa M; Saito Y; Sato M; Takahashi S; Usuda K; Kanma K; Endo C; Sakurada A; Sugita M; Sakuma T
Anticancer Res; 2003; 23(1B):597-600. PubMed ID: 12680153
[TBL] [Abstract][Full Text] [Related]
43. Lung cancer screening: will the controversy extend to its cost-effectiveness?
Klittich WS; Caro JJ
Am J Respir Med; 2002; 1(6):393-401. PubMed ID: 14720026
[TBL] [Abstract][Full Text] [Related]
44. Assessment of lung cancer mortality reduction after chest X-ray screening in smokers: a population-based cohort study in Varese, Italy.
Dominioni L; Poli A; Mantovani W; Pisani S; Rotolo N; Paolucci M; Sessa F; Conti V; D'Ambrosio V; Paddeu A; Imperatori A
Lung Cancer; 2013 Apr; 80(1):50-4. PubMed ID: 23294502
[TBL] [Abstract][Full Text] [Related]
45. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
46. [The need of lung cancer screening: new evidence, new expectations].
Laprus I; Adamek M; Kozielski J
Pneumonol Alergol Pol; 2011; 79(6):419-27. PubMed ID: 22028120
[TBL] [Abstract][Full Text] [Related]
47. [Detection of bronchial cancer. Realities and perspectives].
Tredaniel J; Stucker I; Migaud I; Hirsch A
Rev Mal Respir; 1991; 8(6):543-50. PubMed ID: 1775713
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness of a proposed feasibility study on the detection of early lung carcinoma in Germany.
Nakhosteen JA
Cancer; 2000 Dec; 89(11 Suppl):2494-6. PubMed ID: 11147634
[No Abstract] [Full Text] [Related]
49. Patient Adherence to Screening for Lung Cancer in the US: A Systematic Review and Meta-analysis.
Lopez-Olivo MA; Maki KG; Choi NJ; Hoffman RM; Shih YT; Lowenstein LM; Hicklen RS; Volk RJ
JAMA Netw Open; 2020 Nov; 3(11):e2025102. PubMed ID: 33196807
[TBL] [Abstract][Full Text] [Related]
50. An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case-control study.
Tsukada H; Kurita Y; Yokoyama A; Wakai S; Nakayama T; Sagawa M; Misawa H
Br J Cancer; 2001 Nov; 85(9):1326-31. PubMed ID: 11720469
[TBL] [Abstract][Full Text] [Related]
51. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
52. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
[TBL] [Abstract][Full Text] [Related]
53. Early diagnosis of carcinoma of the lung. Simultaneous screening with chest X-ray and sputum cytology.
Grzybowski S; Coy P
Cancer; 1970 Jan; 25(1):113-20. PubMed ID: 5410302
[No Abstract] [Full Text] [Related]
54. Clinicopathological characteristics of screen-detected lung cancers.
Kawachi R; Watanabe S; Asamura H
J Thorac Oncol; 2009 May; 4(5):615-9. PubMed ID: 19318993
[TBL] [Abstract][Full Text] [Related]
55. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: a community hospital program.
Bechtel JJ; Kelley WR; Petty TL; Patz DS; Saccomanno G
Arch Intern Med; 1994 May; 154(9):975-80. PubMed ID: 8179454
[TBL] [Abstract][Full Text] [Related]
56. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York.
Melamed MR; Flehinger BJ; Zaman MB; Heelan RT; Perchick WA; Martini N
Chest; 1984 Jul; 86(1):44-53. PubMed ID: 6734291
[TBL] [Abstract][Full Text] [Related]
57. Measuring effectiveness of lung cancer screening: from consensus to controversy and back.
Strauss GM
Chest; 1997 Oct; 112(4 Suppl):216S-228S. PubMed ID: 9337293
[TBL] [Abstract][Full Text] [Related]
58. Screening for lung cancer: a systematic review and meta-analysis of controlled trials.
Manser RL; Irving LB; Byrnes G; Abramson MJ; Stone CA; Campbell DA
Thorax; 2003 Sep; 58(9):784-9. PubMed ID: 12947138
[TBL] [Abstract][Full Text] [Related]
59. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force.
Humphrey LL; Teutsch S; Johnson M;
Ann Intern Med; 2004 May; 140(9):740-53. PubMed ID: 15126259
[TBL] [Abstract][Full Text] [Related]
60. Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening.
Black WC
J Natl Cancer Inst; 2000 Aug; 92(16):1280-2. PubMed ID: 10944539
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
